Clinical Trial Comparing Devices Used for Cardioversion of Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 546 participants.

Also called NCT05992623

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 546 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05992623
Other papers using this trial's data
  • Pragmatic Randomized Clinical Trial Comparing Rectilinear Biphasic Waveform and Biphasic Truncated Exponential Waveform Shocks for Cardioversion of Atrial Fibrillation Journal of the American Heart Association, 2026-08-04 DOI, PubMed 42500901

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05992623. Randomized; no masking; primary purpose treatment. Start 2023-07-21 (actual); primary completion 2024-08-14 (actual). Results posted on 2025-09-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial Comparing Devices Used for Cardioversion of Atrial Fibrillation
Intervention (Device)
Zoll external defibrillator
Intervention (Device)
Lifepak external defibrillator
Lead sponsor
Inova Health Care Services (class: other)

Record details

Record id
cardio:ct-nct05992623
Content hash
6f8115c9e3df619b167229c2c81c7c6c279eecf45134fecad58dcebba3173272